OasisLMS

Release date: September 25th, 2026

SCCM Product Code: WEBSPON26B

View the Society of Critical Care Medicine Privacy Statement 

SCCM copyrights the contents of all material available on this site unless otherwise indicated. You may not modify, reproduce or distribute the content on this site, the design or layout of the site, or the SCCM logo without written permission.

This site and/or course may contain active/live links, materials, or information provided by third parties. The active/live links, materials, or information are those of the respective third party and not of the Society or its affiliates. The Society makes no representation with respect to such third-party links, materials, or information, nor does the Society guarantee or endorse the quality, non-infringement, accuracy, completeness, timeliness, or reliability of such third-party links, materials, or information. Use of the links, materials, or information from said third party is voluntary, and your reliance on it should be undertaken only after an independent review of its accuracy, completeness, efficacy, and timeliness.

• Recognize key features of aHUS in acute presentations and outline an efficient triage pathway that supports rapid evaluation and treatment initiation.
• Select and sequence appropriate diagnostic tests to support efficient differential diagnosis and immediate clinical decision-making.
• Describe evidence-based expectations for treatment response in patients with aHUS, including clinical and laboratory parameters associated with renal outcomes.

To provide due process in the evaluation and mediation of grievances concerning ACE activities, this Grievance Procedures Policy was developed. Grievances may concern, but are not limited to, the awarding of credit for individual participation and/or registration fees issues.

• A written complaint or grievance should be submitted to the Education Department.
• The Education Department will attempt to resolve the grievance of the complainant.
• If the initial response is unsatisfactory to the complainant, the matter will be referred to the Chief Executive Officer (CEO)/Executive Vice President (EVP) for action.
• If the response from the CEO/EVP is unsatisfactory to the complainant, the matter will be referred to the SCCM Executive Committee. The ruling of the Executive Committee will be final.

The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been mitigated through an established conflict-of-interest resolution process and have stated that these reported relationships will not have any impact on their ability to provide unbiased content. 

Planners: 

Trisha N. Branan, Pharm D., BCCCP, FCCM
Clinical Professor and Interim Department Head
Department of Clinical and Administrative Pharmacy
University of Georgia College of Pharmacy
Athens, Georgia, USA
No relevant financial relationship(s) to disclose

TJ Boron, MSN, RN
Senior Education Manager
Society of Critical Care Medicine
Mount Prospect, Illinois, USA
No relevant financial relationship(s) to disclose 

Faculty: 

Trisha N. Branan, Pharm D., BCCCP, FCCM
Clinical Professor and Interim Department Head
Department of Clinical and Administrative Pharmacy
University of Georgia College of Pharmacy
Athens, Georgia, USA
No relevant financial relationship(s) to disclose

Louis M. Guzzi, MD, FCCM
Critical Care Physician
AdventHealth
Daytona Beach, Florida, USA
Speakers Bureau: Alexion

Anuja Java, MD
Associate Professor of Medicine
Director, Kidney Transplant John Cochran VA Medical Center
Division of Nephrology
Washington University School of Medicine
St. Louis, MO, USA
Scientific Advisory Board: Alexion, Astra Zeneca Rare Disease, Novartis
Pharmaceuticals Consultant: Apellis, Amgen
Pharmaceuticals Royalty: UptoDate